Jenkins Melissa R, Peven Jamie C, Kubic Lauren, Handen Benjamin L, Krinsky-McHale Sharon J, Hom Christy L, Lee Alice, Tudorascu Dana L, McLachlan Max, Zammit Matthew, Minhas Davneet, Luo Weiquan, Laymon Charles, Lee Joseph H, Lott Ira, Cohen Annie, Ances Beau M, Rosas H Diana, Lai Florence, Zaman Shahid H, Head Elizabeth, Mapstone Mark, Christian Bradley T, Hartley Sigan L
Waisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
J Neurodev Disord. 2025 Apr 11;17(1):19. doi: 10.1186/s11689-025-09604-w.
Adults with Down syndrome (DS) have a 90% lifetime risk for Alzheimer's disease (AD), with neurobiological pathology present decades prior to dementia onset. The profile and timing of cognitive decline in DS is well-documented. However, there is a small body of research on whether Behavioral and Psychological Symptoms of Dementia (BPSD) occur early on in the progression of AD in DS and are associated with early AD pathology (i.e., amyloid-beta [Aβ] and neurofibrillary tau tangles [NFT]).
Data were analyzed from 337 adults with DS (M = 45.13 years, SD = 9.53 years) enrolled in a large cohort study. The Reiss Screen for Maladaptive Behavior (RSMB) measured common behaviors reported in BPSD across up to four study cycles (spaced approximately 16 months apart). Linear mixed models estimated change in BPSD as predicted by baseline (a) dementia status (i.e., cognitively stable, mild cognitive impairment [MCI], or dementia), (b) Aβ positron emission tomography (PET) tracer [C] PiB, and (c) NFT PET tracer [F]AV-1451. Models controlled for chronological age, sex, study site, premorbid intellectual disability level, APOE e4 allele carrier status, psychiatric diagnoses, and psychiatric medication use.
Compared to cognitively stable participants, participants whose status was MCI or dementia, had significantly higher baseline RSMB subdomain scores. Increases in RSMB Depression-Behavioral, Depression-Physical, and Psychosis were observed for participants with MCI. Higher baseline Aβ and NFT were associated with higher RSMB Avoidant at baseline, and increases in RSMB Depression-Physical and Psychosis over time.
BPSD are an important part of AD in DS, particularly during the prodromal stage. Elevated Aβ and NFT predict higher initial avoidance and change in physical depression behaviors and may indicate MCI in adults with DS. Broader increases in BPSD are observed as adults with DS progress from early to late-stage dementia. Clinicians should rule out other possible causes of BPSD when screening for AD, such as stressful life experiences or co-occurring medical conditions. Caregivers of adults with DS should have resources on BPSD management and self-care strategies.
患有唐氏综合征(DS)的成年人患阿尔茨海默病(AD)的终生风险为90%,在痴呆症发病前数十年就存在神经生物学病理变化。DS患者认知衰退的特征和时间已有充分记录。然而,关于痴呆症的行为和心理症状(BPSD)是否在DS患者AD病程早期出现并与早期AD病理(即淀粉样β蛋白[Aβ]和神经纤维缠结[NFT])相关的研究较少。
对参与一项大型队列研究的337名成年DS患者(平均年龄M = 45.13岁,标准差SD = 9.53岁)的数据进行分析。使用赖斯适应不良行为筛查量表(RSMB)在多达四个研究周期(间隔约16个月)中测量BPSD中报告的常见行为。线性混合模型估计BPSD的变化,该变化由基线时的(a)痴呆状态(即认知稳定、轻度认知障碍[MCI]或痴呆)、(b)Aβ正电子发射断层扫描(PET)示踪剂[C]匹兹堡化合物B(PiB)和(c)NFT PET示踪剂[F]AV - 1451预测。模型控制了实际年龄、性别、研究地点、病前智力残疾水平(译者注:此处原文表述似有误,可能是“病前智力水平”)、APOE e4等位基因携带者状态、精神疾病诊断和精神科药物使用情况。
与认知稳定的参与者相比,处于MCI或痴呆状态的参与者基线RSMB子域得分显著更高。观察到MCI患者的RSMB抑郁 - 行为、抑郁 - 身体和精神病症状有所增加。较高的基线Aβ和NFT与基线时较高的RSMB回避得分相关,且随着时间推移RSMB抑郁 - 身体和精神病症状增加。
BPSD是DS患者AD的重要组成部分,尤其是在前驱期。升高的Aβ和NFT预示着更高的初始回避以及身体抑郁行为的变化,可能表明DS成年患者存在MCI。随着DS成年患者从早期痴呆发展到晚期痴呆,BPSD会有更广泛的增加。临床医生在筛查AD时应排除BPSD的其他可能原因,如压力性生活经历或并发的医疗状况。DS成年患者的照顾者应具备BPSD管理和自我护理策略方面的资源。